SEARCH

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    Biocon to merge biologics unit in $5.5 billion deal

    2 days ago

    Biocon has announced a bold step in the biopharmaceutical landscape by merging its biosimilars division, Biocon Biologics, into the parent organization for $5.5 billion. This ambitious strategy is designed to streamline operations and amplify its influence across global markets, especially in diabetes care, cancer treatment, and immune therapies.
    Click here to Read More
    Previous Article
    CM Soren bailed in ED summons case: Future appearance waived; hearing slated for Dec 12
    Next Article
    Bareilly demolition halted by HC: ‘Due process first’; civic body told to hear residents

    Related Topstory Updates:

    Comments (0)

      Leave a Comment